Most Read Pharmaceutical and Health Condition News - August '12 Patients turn to the Internet for news they can trust
AUSTIN, Texas, Sept. 14, 2012 /PRNewswire/ -- dailyRx, Inc., a leading digital publisher, announced today the top five health conditions and medications viewed on the dailyRx News Network™ during August 2012. dailyRx News is syndicated to various hospital, pharmacist and healthcare provider websites, Facebook, Google+, and Twitter channels.
"Millions of consumers are turning to digital publishers to find health news they can trust," said Donald W. Hackett, CEO and Publisher of dailyRx News. "The dailyRx News team eliminates biased research studies and translates medical terminology into a language consumers can more easily understand."
According to the Pew Research Center, 80 percent of all Internet users look for health information online, and 66 percent of them are seeking information about a specific disease or medical problem. Additionally, 40 percent of Internet searches are related to medications.
Top five conditions viewed during August 2012:
- Cancer – 5.2MM PVs
- Arthritis – 4.9MM PVs
- HIV/AIDS – 3.2MM PVs
- Allergies – 2.5MM PVs
- Diabetes – 2.2MM PVs
Top five medications viewed during August 2012:
- Humira, Abbott Laboratories
- Nexium, AstraZeneca
- Plavix, Sanofi Pharmaceuticals & Bristol-Myers Squibb
- Cymbalta, Eli Lilly and Company
- Abilify, Bristol-Myers Squibb & Otsuka Pharmaceutical
"As the dailyRx digital audience continues to expand, more and more users are reading about prescription medications specific to their health condition. These empowered patients are taking action upon their research and offer a great opportunity for health marketers to reach their target audience at a critical time: during the learning cycle," said Hackett.
The dailyRx News Network is an emerging leader in publishing health news for consumers and patients alike. dailyRx publishes, aggregates, and syndicates doctor-reviewed news covering a wide range of health conditions, medications, over-the-counter products, and nutraceutical compounds. dailyRx's original content is written in positive, unbiased, easy-to-understand language and reviewed for efficacy by doctors, pharmacists and therapists. dailyRx, Inc. is owned by Patient Conversation Media, Inc.
About Patient Conversation Media, Inc.
Patient Conversation Media, Inc. (PCMi) is a technology-driven media enterprise focused on the digital evolution within the health industry. PCMi's cloud-based Content-as-a-Service platform powers its DTC web sites, publishes original content, distributes patient education solutions, and deploys a suite of appointment management solutions across Internet, Mobile, Social Media, and Telephony user experiences. PCMi's national network of physicians, pharmacists and behavioral health providers serves as the primary distribution channel for its solutions. PCMi's portfolio of owned and operated brands includes www.dailyRx.com, www.RxWiki.com, www.1-800-Oncologist.com and www.1-800-Therapist.com.
SOURCE dailyRx, Inc.